BioSpace News Archive

Regularly testing New England Biolabs employees helps maintain the supply of enzymes for crucial scientific research, including developing COVID-19 vaccines.

Viriom Inc (Viriom) announces that its antiviral drug Elpida®(elsulfavirine) has been included in the preferred first-line antiretroviral therapy (ART) regimens by the Ministry of Health of the Russian Federation according to updated clinical guidelines for the treatment of HIV infection in adults and children.

Ulbrich understands the need for rapid Medical Device development cycles. With the new Ulbrich Braid Wire Accelerator™ Program, timelines and specific design performance characteristics are faster and more precise than ever before.

BioKansas announces their new strategic plan for 2021-2025 that focuses on five transformative goals. The new strategic plan aims to have substantial impacts on the bioscience industry and broader economy in Kansas through building a sustainable nationally competitive bioscience enterprise with a strong diverse workforce.

Dr. Henderson’s career includes contributions in toxicology, spanning 30 years of research at Lovelace Biomedical.

Connecticut is among an initial 11 state rollout and part of the company’s larger plan to expand access to COVID-19 vaccines at CVS Pharmacy locations across the country

California is among an initial 11 state rollout and part of the company’s larger plan to expand access to COVID-19 vaccines at CVS Pharmacy locations across the country

HistoSonics, developer of a non-invasive platform and novel sonic beam therapy, announced today the treatment of the first patient in the #HOPE4LIVER US Study.

Massachusetts is among an initial 11 state rollout and part of the company’s larger plan to expand access to COVID-19 vaccines at CVS Pharmacy locations across the country

New York is among an initial 11 state rollout and part of the company’s larger plan to expand access to COVID-19 vaccines at CVS Pharmacy locations across the country